Author
Listed:
- Bo Ye
(Shanghai Jiaotong University
Guangzhou University)
- Dandan Fan
(Wenzhou Medical University)
- Weiwei Xiong
(Guangzhou University)
- Min Li
(Guangzhou University)
- Jian Yuan
(Wenzhou Medical University)
- Qi Jiang
(Wenzhou Medical University)
- Yuting Zhao
(Guangzhou University
Guangzhou University & Zhongshan People’s Hospital Joint Biomedical Institute)
- Jianxiang Lin
(Guangzhou University)
- Jie Liu
(Guangzhou University)
- Yilv Lv
(Shanghai Jiaotong University)
- Xiongjun Wang
(Guangzhou University)
- Zhigang Li
(Shanghai Jiaotong University)
- Jianzhong Su
(Wenzhou Medical University
Wenzhou Institute, University of Chinese Academy of Sciences)
- Yunbo Qiao
(Guangzhou University)
Abstract
The role of cis-elements and their aberrations remains unclear in esophageal squamous cell carcinoma (ESCC, further abbreviated EC). Here we survey 28 H3K27ac-marked active enhancer profiles and 50 transcriptomes in primary EC, metastatic lymph node cancer (LNC), and adjacent normal (Nor) esophageal tissues. Thousands of gained or lost enhancers and hundreds of altered putative super-enhancers are identified in EC and LNC samples respectively relative to Nor, with a large number of common gained or lost enhancers. Moreover, these differential enhancers contribute to the transcriptomic aberrations in ECs and LNCs. We also reveal putative driver onco-transcription factors, depletion of which diminishes cell proliferation and migration. The administration of chemical inhibitors to suppress the predicted targets of gained super-enhances reveals HSP90AA1 and PDE4B as potential therapeutic targets for ESCC. Thus, our epigenomic profiling reveals a compendium of reprogrammed cis-regulatory elements during ESCC carcinogenesis and metastasis for uncovering promising targets for cancer treatment.
Suggested Citation
Bo Ye & Dandan Fan & Weiwei Xiong & Min Li & Jian Yuan & Qi Jiang & Yuting Zhao & Jianxiang Lin & Jie Liu & Yilv Lv & Xiongjun Wang & Zhigang Li & Jianzhong Su & Yunbo Qiao, 2021.
"Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis,"
Nature Communications, Nature, vol. 12(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24813-2
DOI: 10.1038/s41467-021-24813-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24813-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.